Share
Daily Politics from the New Statesman
How can life sciences investment make the UK healthier? | Sponsored
The UK is on course for a huge rise in preventable illness. The Health Foundation charity predicts that by 2040, one in five adults will be living with a serious condition, such as cancer, dementia or heart disease. Meanwhile, economic activity is stagnating, with roughly 2.8 million people currently out of work due to ill health, according to the latest figures from the Office for National Statistics.
Our world-leading life sciences sector has the capacity to help reverse this trend. In 2021 alone, it contributed £43.3bn to the UK economy, and supported 646,000 jobs. With the right investment, it could add an additional £68bn to GDP over the next 30 years, create 85,000 more jobs and result in a 40 per cent decrease in disease burden across the UK.
This episode, in partnership with professional services firm PwC, explores how greater investment into vital disease areas such as cancer, obesity and immunology could make British society physically and financially healthier.
Emma Haslett is joined by Chi Onwurah, the shadow minister for science, research and innovation; Dr Dan Mahony, chair of the UK BioIndustry Association (BIA) and the government’s life sciences investment envoy; and Stephen Aherne, pharmaceutical and life sciences leader at PwC UK.
If you enjoyed this podcast you can find more of Spotlight's policy reporting in our standalone Spotlight podcast feed, or at newstatesman.com/spotlight
LISTEN AD-FREE:
📱Download the New Statesman app
MORE FROM THE NEW STATESMAN:
❓ Ask a question – we answer them every Friday
⏰ Get our daily politics newsletter every morning
✍️ Enjoy the best of our writing via email every Saturday
More episodes
View all episodes
Starmer and Trump's relationship at an all time low
28:02|Angry about the lack of support for his war in Iran, Donald Trump stated that he didn’t need any help from the UK, despite using British airbases for strikes. In an angry social media rant, he also called Keir Starmer a “loser” and “no Winston Churchill”.Just a day later, the two leaders had a call to discuss military cooperation. Can relations be repaired? And is Westminster telling us the whole story?Anoosh Chakelian is joined by US Correspondent Freddie Hayward.
”Won’t somebody think of the labradoodles?” | Will and Anoosh’s weekly round up
36:22|Despite Dubai’s proximity to Iran, is it safer than Sadiq Khan’s London? Do young people have a different perspective on class? And could the corgi be banned?Will and Anoosh round up their picks of news stories from the week.
What is the future for jury trials?
30:40|On Tuesday 10 March, MPs will debate the Courts and Tribunals Bill, in what could be the biggest shakeup of the justice system since the 1970s.To tackle the Crown Court backlog of over 80,000 cases, the government has put forward proposals to radically reform which cases are heard where, including restricting the right to a trial by jury in all but the most serious cases.Sarah Sackman, Minister of State for Courts and Legal Services, speaks to Rachel Cunliffe to discuss the legislation and its potential impact on British justice.
Exclusive: the progressive voters abandoning Labour
20:02|Labour is losing the voters it used to count on, a new study reveals.In the aftermath of the Green Party’s triumph in the Gorton and Denton by-election, and with local elections in London councils and other major cities coming up, Labour is losing the left progressive voters it could once rely on having “nowhere else to go”.Now, the biggest study ever of these voters – shared exclusively with the New Statesman – reveals the true risk to Labour’s future of leaving them behind.This work, done by surveying 10,000 voters and a randomised control trial style approach, has found out who the so-called progressive defectors are, why they’re deserting Labour, and what impact this could have on Labour’s electoral prospects.Anoosh Chakelian is joined by Steve Akehurst of Persuasion UK who co-authored this report with 38 Degrees.
Was Rachel Reeves’ spring statement out of date on arrival?
23:12|Yesterday, the Chancellor Rachel Reeves delivered her spring statement - an economic update - to the commons.With the news completely dominated by conflict in the Middle East, you would be forgiven for not noticing. In fact, many have deduced that this was exactly what the government were hoping for.Anoosh Chakelian is joined by Will Dunn to discuss.
Should the phrase "special relationship" be banned?
31:55|Yesterday afternoon in the Commons, Keir Starmer took a stance against Trump's attacks on Iran. The US President has expressed his dissatisfaction with the Prime Minister.Is a rift developing? Should the UK be pivoting away from the US and towards Europe? And should talk of the "special relationship" be banned from the government's parlance?Oli Dugmore is joined by journalist, author, and ex-Foreign Office special adviser Ben Judah to discuss.
Iran war: Trump is playing into Putin's hands.
23:24|While the US bombs Iran, the Kremlin will see immediate advantages for Russia.Vladimir Putin expressed “deep condolences” to the people of Iran over the killing of supreme leader Ayatollah Ali Khamenei by US and Israeli forces.The Russian president – currently leading his own brutal and illegal war in Ukraine – condemned what he called Khamenei’s “assassination” as a “cynical violation of all norms of human morality and international law”.Russia and Iran are long-term “strategic partners”. They signed a new treaty in January last year.But while Putin offers consoling words to Iran, the Kremlin will undoubtedly have eyes on the potential benefits to them of a US-Israel war on Russia’s ally.So, is Trump’s war in Iran playing into Russia’s hands?
Does Trump have an endgame in Iran?
45:20|Fiona Hill, former presidential advisor, joins Megan Gibson.
Rare diseases: from lived experience to lasting treatments | Sponsored
21:16|To mark Rare Disease Day, this special Spotlight episode explores why rare diseases - affecting an estimated one in 17 people in the UK – still face years of diagnostic delays and limited treatment options.Host Sarah Darwood speaks to CEO of LifeArc Dr Sam Barrell and Terry Pirovalakis, whose son Michael has been diagnosed with the rare neurological disorder SPG50. Their discussion looks at the reality of the “diagnostic odyssey”; gaps in data, investment and regulatory pathways; and the financial and structural challenges that limit progress in rare conditions.They also explore the growing role of parents as advocates and innovators, the case for a national rare disease champion, and why a more joined-up approach across government, regulators, industry and charities is essential to delivering faster diagnoses and access to life-changing therapies.This New Statesman podcast episode has been fully funded by LifeArc.Find out more about LifeArc’s Taskforce Report and recommendations.